• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型纯合 CD46 变体,具有 C 异构体表达,影响非典型溶血性尿毒症综合征中 C3b 的失活。

Novel homozygous CD46 variant with C-isoform expression affects C3b inactivation in atypical hemolytic uremic syndrome.

机构信息

Department of Biomedicine, Aarhus University, Aarhus C, Denmark.

Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark.

出版信息

Eur J Immunol. 2022 Oct;52(10):1610-1619. doi: 10.1002/eji.202249838. Epub 2022 Aug 31.

DOI:10.1002/eji.202249838
PMID:35987516
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9804674/
Abstract

Atypical hemolytic uremic syndrome (aHUS) is a thrombotic microangiopathy that may lead to organ failure. Dysregulation of the complement system can cause aHUS, and various disease-related variants in the complement regulatory protein CD46 are described. We here report a pediatric patient with aHUS carrying a hitherto unreported homozygous variant in CD46 (NM_172359.3:c.602C>T p.(Ser201Leu)). In our functional analyses, this variant caused complement dysregulation through three separate mechanisms. First, CD46 surface expression on the patient's blood cells was significantly reduced. Second, stably expressing CD46(Ser201Leu) cells bound markedly less to patterns of C3b than CD46 WT cells. Third, the patient predominantly expressed the rare isoforms of CD46 (C dominated) instead of the more common isoforms (BC dominated). Using BC1 and C1 expressing cell lines, we found that the C1 isoform bound markedly less C3b than the BC1 isoform. These results highlight the coexistence of multiple mechanisms that may act synergistically to disrupt CD46 function during aHUS development.

摘要

非典型溶血尿毒症综合征(aHUS)是一种血栓性微血管病,可导致器官衰竭。补体系统失调可导致 aHUS,并且已描述了补体调节蛋白 CD46 中的各种与疾病相关的变异体。我们在此报告了一名患有 aHUS 的儿科患者,其携带 CD46 中迄今未报道的纯合变异体(NM_172359.3:c.602C>T p.(Ser201Leu))。在我们的功能分析中,该变异体通过三种独立的机制引起补体失调。首先,患者血细胞表面的 CD46 表达显著降低。其次,稳定表达 CD46(Ser201Leu)的细胞与 CD46 WT 细胞相比,与 C3b 的结合明显减少。第三,患者主要表达罕见的 CD46 同工型(C 为主),而不是更常见的同工型(BC 为主)。使用表达 BC1 和 C1 的细胞系,我们发现 C1 同工型与 BC1 同工型相比,与 C3b 的结合明显减少。这些结果强调了多种机制可能协同作用破坏 aHUS 发展过程中 CD46 功能的共存。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b86/9804674/37053ae88794/EJI-52-1610-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b86/9804674/9f3e7bfd1466/EJI-52-1610-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b86/9804674/9ebba65c01da/EJI-52-1610-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b86/9804674/37053ae88794/EJI-52-1610-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b86/9804674/9f3e7bfd1466/EJI-52-1610-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b86/9804674/9ebba65c01da/EJI-52-1610-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b86/9804674/37053ae88794/EJI-52-1610-g003.jpg

相似文献

1
Novel homozygous CD46 variant with C-isoform expression affects C3b inactivation in atypical hemolytic uremic syndrome.新型纯合 CD46 变体,具有 C 异构体表达,影响非典型溶血性尿毒症综合征中 C3b 的失活。
Eur J Immunol. 2022 Oct;52(10):1610-1619. doi: 10.1002/eji.202249838. Epub 2022 Aug 31.
2
Functional characterization of two novel non-synonymous alterations in CD46 and a Q950H change in factor H found in atypical hemolytic uremic syndrome patients.在非典型溶血尿毒综合征患者中发现的CD46基因两个新型非同义改变以及补体因子H的Q950H改变的功能特征。
Mol Immunol. 2015 Jun;65(2):367-76. doi: 10.1016/j.molimm.2015.02.013. Epub 2015 Feb 28.
3
Genetic and functional analysis of two missense mutations in CD46 predispose to postpartum atypical hemolytic uremic syndrome.两种 CD46 错义突变的遗传和功能分析导致产后非典型溶血尿毒症综合征。
Clin Chim Acta. 2020 Apr;503:61-69. doi: 10.1016/j.cca.2020.01.009. Epub 2020 Jan 13.
4
Molecular Studies and an Complement Assay on Endothelium Highlight the Genetic Complexity of Atypical Hemolytic Uremic Syndrome: The Case of a Pedigree With a Null CD46 Variant.内皮细胞的分子研究及补体检测凸显非典型溶血尿毒综合征的遗传复杂性:一个携带CD46无效变异的家系病例
Front Med (Lausanne). 2020 Nov 3;7:579418. doi: 10.3389/fmed.2020.579418. eCollection 2020.
5
The molecular and structural bases for the association of complement C3 mutations with atypical hemolytic uremic syndrome.补体C3突变与非典型溶血尿毒综合征关联的分子和结构基础。
Mol Immunol. 2015 Aug;66(2):263-73. doi: 10.1016/j.molimm.2015.03.248. Epub 2015 Apr 11.
6
Genetic Analysis of 400 Patients Refines Understanding and Implicates a New Gene in Atypical Hemolytic Uremic Syndrome.对 400 名患者进行基因分析,深化了对非典型溶血尿毒综合征的认识并提示了一个新基因的作用。
J Am Soc Nephrol. 2018 Dec;29(12):2809-2819. doi: 10.1681/ASN.2018070759. Epub 2018 Oct 30.
7
Atypical Hemolytic Uremic Syndrome Triggered by Acute Pancreatitis in a Patient with a Membrane Cofactor Protein (CD46) Genetic Variant.一名具有膜辅因子蛋白(CD46)基因变异的患者因急性胰腺炎引发非典型溶血性尿毒症综合征。
Intern Med. 2024 Oct 1;63(19):2651-2654. doi: 10.2169/internalmedicine.3169-23. Epub 2024 Feb 26.
8
[Atypical hemolytic-uremic syndrome related to abnormalities within the complement system].[与补体系统异常相关的非典型溶血尿毒综合征]
Rev Med Interne. 2011 Apr;32(4):232-40. doi: 10.1016/j.revmed.2009.09.039. Epub 2011 Mar 3.
9
Complement regulator CD46: genetic variants and disease associations.补体调节蛋白CD46:基因变异与疾病关联
Hum Genomics. 2015 Jun 10;9(1):7. doi: 10.1186/s40246-015-0029-z.
10
Atypical Hemolytic Uremic Syndrome-Associated FHR1 Isoform FHR1*B Enhances Complement Activation and Inflammation.非典型溶血尿毒综合征相关 FHR1 同种型 FHR1*B 增强补体激活和炎症反应。
Front Immunol. 2022 Jan 21;13:755694. doi: 10.3389/fimmu.2022.755694. eCollection 2022.

引用本文的文献

1
Genetic investigation of Nordic patients with complement-mediated kidney diseases.北欧补体介导性肾脏疾病患者的遗传学研究。
Front Immunol. 2023 Sep 7;14:1254759. doi: 10.3389/fimmu.2023.1254759. eCollection 2023.

本文引用的文献

1
CD46 Isoforms Influence the Mode of Entry by Human Herpesvirus 6A/B in T Cells.CD46 同种型影响人类疱疹病毒 6A/B 进入 T 细胞的方式。
J Virol. 2022 Mar 9;96(5):e0155721. doi: 10.1128/JVI.01557-21. Epub 2022 Jan 12.
2
Membrane cofactor protein (MCP; CD46): deficiency states and pathogen connections.膜辅助蛋白(MCP;CD46):缺乏状态与病原体的关联。
Curr Opin Immunol. 2021 Oct;72:126-134. doi: 10.1016/j.coi.2021.04.005. Epub 2021 May 15.
3
The tetraspanin protein CD9 modulates infection with human herpesvirus 6A and 6B in a CD46-dependent manner.
四跨膜蛋白CD9以CD46依赖性方式调节人疱疹病毒6A和6B的感染。
J Virol. 2021 Mar 25;95(8). doi: 10.1128/JVI.02259-20. Epub 2021 Jan 27.
4
The genetics of atypical hemolytic uremic syndrome.非典型溶血性尿毒症综合征的遗传学
Med Genet. 2018;30(4):400-409. doi: 10.1007/s11825-018-0216-0. Epub 2018 Dec 21.
5
Mutations in () gene in Indian children with hemolytic uremic syndrome.印度溶血尿毒综合征患儿()基因的突变
Clin Kidney J. 2018 Apr;11(2):198-203. doi: 10.1093/ckj/sfx078. Epub 2017 Aug 10.
6
Statistical Validation of Rare Complement Variants Provides Insights into the Molecular Basis of Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy.罕见补体变异的统计学验证为非典型溶血尿毒症综合征和 C3 肾小球病的分子基础提供了新见解。
J Immunol. 2018 Apr 1;200(7):2464-2478. doi: 10.4049/jimmunol.1701695. Epub 2018 Mar 2.
7
A potent complement factor C3-specific nanobody inhibiting multiple functions in the alternative pathway of human and murine complement.一种强效的补体因子 C3 特异性纳米抗体,可抑制人源和鼠源补体替代途径中的多种功能。
J Biol Chem. 2018 Apr 27;293(17):6269-6281. doi: 10.1074/jbc.RA117.001179. Epub 2018 Mar 1.
8
Functional and structural insight into properdin control of complement alternative pathway amplification.关于备解素对补体替代途径放大作用的功能和结构见解。
EMBO J. 2017 Apr 13;36(8):1084-1099. doi: 10.15252/embj.201696173. Epub 2017 Mar 6.
9
Haemolytic uraemic syndrome.溶血尿毒综合征。
Lancet. 2017 Aug 12;390(10095):681-696. doi: 10.1016/S0140-6736(17)30062-4. Epub 2017 Feb 25.
10
Non-random pairing of CD46 isoforms with skewing towards BC2 and C2 in activated and memory/effector T cells.在活化的以及记忆/效应T细胞中,CD46亚型的非随机配对偏向于BC2和C2。
Sci Rep. 2016 Oct 14;6:35406. doi: 10.1038/srep35406.